Tarsons Products Ltd

Director reappointment

• Type: Re-appointment as Director; Chairman and Managing Director.
• Effective: Re-appointment at AGM on Sep 24, 2026.
• MD term: 26 Jul 2023 to 25 Jul 2028 (5 years).
• Reason: Retirement by rotation.
• Profile: B.Sc from St. Xavier's College; 40+ years in plastics labware and related sectors.
• Relationship: Father of Aryan Sehgal, Whole-Time Director.
• Not debarred from holding office.

AGM Details

• AGM held on 24 Sep 2026 at 12:00 P.M. IST via VC/OAVM.

Resolutions & Voting Outcomes

• Ordinary: Standalone financials adopted; in-favour ~99.9996%.
• Ordinary: Consolidated financials adopted; in-favour ~99.9996%.
• Ordinary: Director Sanjive Sehgal to be re-appointed by rotation.
• Ordinary: Related party transactions with Nerbe approved; in-favour ~99.993%.
• Special: Waiver of excessive managerial remuneration approved; in-favour ~99.903%.

Director Changes

• Director Sanjive Sehgal to be re-appointed by rotation.

Material Related Party Transactions

• Approval of Nerbe Plus KG transactions; nature: step-down subsidiary; value not disclosed.

Auditors

• No auditor appointments or changes announced.

Tarsons Products Limited – Trading Window closed from October 01, 2026 until 48 hours after the declaration and dissemination of the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026.

Meeting Details

• Date and time: Wednesday, 30 Sep 2026, 05:00–06:00 IST.
• Hosted by: Arihant Capital.
• Nature: Group meeting.
• Mode: Virtual.

Participants

• Key company participants: CFO; Company Secretary & Compliance Officer.

Purpose

• Purpose: Analyst/institutional investor group meeting; based on public information.

AGM details

• Date and time: Sep 24, 2026, 12:00 PM IST; mode: VC/OAVM.
• Meeting concluded at 1:05 PM IST.
• Quorum achieved: 70.84% of voting rights attended via VC.
• Remote e-voting: Sep 21–23, 2026; 15 minutes post-meeting voting.

Ordinary resolutions

• Adopt standalone financial statements for FY ended Mar 31, 2026.
• Adopt consolidated financial statements for FY ended Mar 31, 2026.
• Reappoint director retiring by rotation (Sanjive Sehgal).

Material approvals and special items

• Approve material related party transactions with Nerbe Plus GmbH & Co. KG.
• Waiver of excessive managerial remuneration paid to directors in 2025-26.

Voting outcomes

• Outcomes of resolutions not disclosed in the filing.

Clarification on volume spurt

• No pending/undisclosed material information; volume movement is market-driven.
• Discloses events to exchanges within prescribed timelines per SEBI LODR.